J06 Immune sera and immunoglobulins Sueros inmunes e inmunoglobulinas Immune sera and immunoglobulins Immune sera and immunoglobulins L2
Source: Wikidata · CC0 1.0 Fuente: Wikipedia · CC BY-SA 4.0 来源:维基数据 · CC0 1.0 · 回退名 (en) 來源:維基數據 · CC0 1.0 · 回退名 (en)
ATC level L2 · Search this class · Consumer categories
Child classes
J06Aantiserum suero inmunológico 抗血清 抗血清J06Bimmunoglobulin therapy terapia con inmunoglobulina 免疫球蛋白疗法 免疫球蛋白療法
Active ingredients in this class
51 active ingredients 51 principios activos 51 个活性成分 51 個有效成分
Each market now shows one aggregated status: a market counts as on sale if it has any active record; individual record statuses are shown in the details. The same market can also have several registration records with different statuses, so each market appears only once here; that is a record fact, not a safety judgement.
A missing name is marked in its row only when it is the exception; when most names lack it, the list stays unmarked.
- Nirsevimab
J06BD08active US GB CA SG CN · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA SG CN ES MX TW EU FR · unknown AU HK - Palivizumab
J06BD01active GB SG TW EU FR · and 6 more y 6 más 另有 6 个 另有 6 個
active GB SG TW EU FR · discontinued CA ES · unknown AU HK - Clesrovimab
J06BD10active US GB CA SG ES · and 4 more y 4 más 另有 4 个 另有 4 個
active US GB CA SG ES MX EU · unknown AU - Hepatitis B Immunoglobulin
J06BBactive GB CA SG CN · and 3 more y 3 más 另有 3 个 另有 3 個
active GB CA SG CN · unknown AU HK - Bezlotoxumab
J06BC03active US GB CN · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CN · discontinued ES FR · withdrawn EU - Sotrovimab
J06BD05active GB · and 6 more y 6 más 另有 6 个 另有 6 個
active GB · discontinued FR · withdrawn CA ES EU - Tixagevimab
J06BD03active GB · and 6 more y 6 más 另有 6 个 另有 6 個
active GB · discontinued CA · withdrawn ES EU FR - Immunoglobulin
J06BA01active CA SG FR · and 2 more y 2 más 另有 2 个 另有 2 個
active CA SG FR · unknown AU - Rabies Immunoglobulin
J06BBactive GB CA CN · and 2 more y 2 más 另有 2 个 另有 2 個
active GB CA CN · unknown AU - Cytomegalovirus Immunoglobulin
J06BB09active GB CA SG · and 2 more y 2 más 另有 2 个 另有 2 個
active GB CA SG · unknown AU - Casirivimab
J06BD07active GB · and 4 more y 4 más 另有 4 个 另有 4 個
active GB · withdrawn CA ES EU - Sipavibart
J06BD09active CA EU · and 4 more y 4 más 另有 4 个 另有 4 個
active CA EU · discontinued ES · unknown AU - Regdanvimab
J06BBactive GB · and 6 more y 6 más 另有 6 个 另有 6 個
active GB · discontinued ES · withdrawn EU · unknown AU - Inmunoglobulina G Humana
J06BA02active CN ES · and 2 more y 2 más 另有 2 个 另有 2 個
active CN ES · discontinued MX - 人凝血因子ⅦA
J06AASalt form: A型肉毒毒素
A型肉毒毒素active SG CN FR
active SG CN FR - Immunoglobulin G
J06BA01active CA SG · and 2 more y 2 más 另有 2 个 另有 2 個
active CA SG · unknown AU - Obiltoxaximab
J06BC04active US CA · and 2 more y 2 más 另有 2 个 另有 2 個
active US CA · withdrawn EU - Tetanus Immunoglobulin
J06BBactive CN · and 2 more y 2 más 另有 2 个 另有 2 個
active CN · unknown AU - Tetanus Immunoglobulin Human
J06BB02active GB CA
active GB CA - Varicella-Zoster Immunoglobulin
J06BB03active GB CA
active GB CA - Botulinum Antitoxin
J06AA04active GB · and 2 more y 2 más 另有 2 个 另有 2 個
active GB · discontinued CA - Diphtheria Antitoxin
J06AA01active GB · and 2 more y 2 más 另有 2 个 另有 2 個
active GB · discontinued CA - Bamlanivimab
J06Bactive GB · and 2 more y 2 más 另有 2 个 另有 2 個
active GB · discontinued CA - Inmunoglobulina Anti Citomegalovirus
J06BB09active ES · and 2 more y 2 más 另有 2 个 另有 2 個
active ES · unknown MX - Anti-D
J06BB01active CA
active CA - 白葡萄球菌
J06BBactive CN
active CN - 破伤风抗毒素
J06AAactive CN
active CN - 马破伤风免疫球蛋白(F(ab')2)
J06BBactive CN
active CN - Inmunoglobulina Anti Hepatitis B Humana
J06BB04active ES
active ES - 灭活白葡萄球菌
J06BBactive CN
active CN - 细菌溶解产物
J06BBactive CN
active CN - Respiratory Syncytial Virus Immune Globulin Intravenous
J06BA02discontinued CA
discontinued CA - 抗狂犬病血清
J06AAactive CN
active CN - 静注乙型肝炎人免疫球蛋白
J06BBactive CN
active CN - 白葡奈氏菌
J06BBactive CN
active CN - Ansuvimab
J06BD04active US
active US - Human Immunoglobulins
J06BB02discontinued CA
discontinued CA - Inmunoglobulina Anti D (Rh)
J06BB01active ES
active ES - Inmunoglobulina Antirrábica Humana
J06BB05active ES
active ES - Inmunoglobulina Antitetánica Humana
J06BB02active ES
active ES - 抗银环蛇毒血清
J06AAactive CN
active CN - 泽美洛韦玛佐瑞韦单抗
J06BBactive CN
active CN - 冻干静注乙型肝炎人免疫球蛋白
J06BBactive CN
active CN - 抗五步蛇毒血清
J06AAactive CN
active CN - 抗蝮蛇毒血清
J06AAactive CN
active CN - 抗眼镜蛇毒血清
J06AAactive CN
active CN - Anthrax Immunoglobulin
J06BB19active CA
active CA - Antivenin Crotaline Polyvalent
J06AA03discontinued CA
discontinued CA - Botulinum Antitoxin Serotype A
J06AA04active CA
active CA - Raxibacumab
J06BB18active US
active US - Vaccinia Immunoglobulin
J06BB07active CA
active CA
Class names are editorial translations or come from Wikipedia (CC BY-SA 4.0) / Wikidata (CC0); each ATC page lists the exact source, licence and link for every language. Only the ATC code and the WHO hierarchy are authoritative.
Notes & licences
Status badges summarise the product records held for each ingredient (active / discontinued / withdrawn / unknown), and the market codes after each badge show where that status is recorded. Only some registers publish a status column: CA, ES and MX do; AU and HK have no status column and are recorded as unknown; CN, US, GB, TW and SG records are on the register and marked active.
Class and category names are editorial or AI-assisted translations; only the ATC code and the WHO hierarchy are authoritative.
ATC codes and hierarchy reference the WHO Collaborating Centre for Drug Statistics Methodology ATC/DDD Index (copyright WHOCC; the index itself is not reproduced). Ingredient/strength facts come from the regulator records listed on About.